These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

50 related items for PubMed ID: 2274638

  • 21. Quetiapine in combination with citalopram in patients with unipolar psychotic depression.
    Konstantinidis A, Hrubos W, Nirnberger G, Windhager E, Lehofer M, Aschauer H, Kasper S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan 30; 31(1):242-7. PubMed ID: 16962224
    [Abstract] [Full Text] [Related]

  • 22. A 12-week, double-blind, placebo-controlled trial of galantamine adjunctive treatment to conventional antipsychotics for the cognitive impairments in chronic schizophrenia.
    Lee SW, Lee JG, Lee BJ, Kim YH.
    Int Clin Psychopharmacol; 2007 Mar 30; 22(2):63-8. PubMed ID: 17293705
    [Abstract] [Full Text] [Related]

  • 23. Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled study.
    Paleacu D, Barak Y, Mirecky I, Mazeh D.
    Int J Geriatr Psychiatry; 2008 Apr 30; 23(4):393-400. PubMed ID: 17879256
    [Abstract] [Full Text] [Related]

  • 24. Quetiapine, a novel antipsychotic: experience in elderly patients with psychotic disorders. Seroquel Trial 48 Study Group.
    McManus DQ, Arvanitis LA, Kowalcyk BB.
    J Clin Psychiatry; 1999 May 30; 60(5):292-8. PubMed ID: 10362435
    [Abstract] [Full Text] [Related]

  • 25. Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.
    Jahn H, Schick M, Kiefer F, Kellner M, Yassouridis A, Wiedemann K.
    Arch Gen Psychiatry; 2004 Dec 30; 61(12):1235-44. PubMed ID: 15583115
    [Abstract] [Full Text] [Related]

  • 26. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY, Belous AI, Yevtushenko YG, Gusinin SE, Buzik OJ, Agibalova TV.
    Clin Ther; 2007 Nov 30; 29(11):2319-32. PubMed ID: 18158074
    [Abstract] [Full Text] [Related]

  • 27. A 12-week, double-blind, placebo-controlled trial of donepezil as an adjunct to haloperidol for treating cognitive impairments in patients with chronic schizophrenia.
    Lee BJ, Lee JG, Kim YH.
    J Psychopharmacol; 2007 Jun 30; 21(4):421-7. PubMed ID: 17092979
    [Abstract] [Full Text] [Related]

  • 28. The measurement of aggressive behavior: reflections on the use of the Overt Aggression Scale and the Modified Overt Aggression Scale.
    Ratey JJ, Gutheil CM.
    J Neuropsychiatry Clin Neurosci; 1991 Jun 30; 3(2):S57-60. PubMed ID: 1821223
    [No Abstract] [Full Text] [Related]

  • 29. Depression during treatment with beta-blockers: results from a double-blind placebo-controlled study.
    Sorgi P, Ratey J, Knoedler D, Arnold W, Cole L.
    J Neuropsychiatry Clin Neurosci; 1992 Jun 30; 4(2):187-9. PubMed ID: 1627981
    [Abstract] [Full Text] [Related]

  • 30. Effect of nadolol on flushing reactions in rosacea.
    Wilkin JK.
    J Am Acad Dermatol; 1989 Feb 30; 20(2 Pt 1):202-5. PubMed ID: 2521641
    [Abstract] [Full Text] [Related]

  • 31. Nadolol in the treatment of central serous retinopathy.
    Browning DJ.
    Am J Ophthalmol; 1993 Dec 15; 116(6):770-1. PubMed ID: 8250086
    [No Abstract] [Full Text] [Related]

  • 32. Carbamazepine for the violent psychiatric patient.
    Luchins DJ.
    Lancet; 1983 Apr 02; 1(8327):766. PubMed ID: 6132108
    [No Abstract] [Full Text] [Related]

  • 33. "Nadolol in migrainous patients".
    Pascual J.
    Headache; 1988 Oct 02; 28(9):623-4. PubMed ID: 3248940
    [No Abstract] [Full Text] [Related]

  • 34. Pharmacological interventions for antisocial personality disorder.
    Khalifa NR, Gibbon S, Völlm BA, Cheung NH, McCarthy L.
    Cochrane Database Syst Rev; 2020 Sep 03; 9(9):CD007667. PubMed ID: 32880105
    [Abstract] [Full Text] [Related]

  • 35. Successful management of postictal violence with pindolol in temporal lobe epilepsy.
    Abd Wahab W, Collinson K, Gross DW.
    Epilepsy Behav Rep; 2019 Sep 03; 12():100346. PubMed ID: 31799509
    [Abstract] [Full Text] [Related]

  • 36. Pharmacological management of acute and persistent aggression in forensic psychiatry settings.
    Citrome L, Volavka J.
    CNS Drugs; 2011 Dec 01; 25(12):1009-21. PubMed ID: 22133324
    [Abstract] [Full Text] [Related]

  • 37. Pharmacological interventions for antisocial personality disorder.
    Khalifa N, Duggan C, Stoffers J, Huband N, Völlm BA, Ferriter M, Lieb K.
    Cochrane Database Syst Rev; 2010 Aug 04; (8):CD007667. PubMed ID: 20687091
    [Abstract] [Full Text] [Related]

  • 38. Clinical and administrative consequences of a reduced census on a psychiatric intensive care unit.
    Citrome L, Green L, Fost R.
    Psychiatr Q; 1995 Aug 04; 66(3):209-17. PubMed ID: 7568529
    [Abstract] [Full Text] [Related]

  • 39. A double-blind, placebo-controlled study of adjunctive nadolol in the management of violent psychiatric patients.
    Alpert M, Allan ER, Citrome L, Laury G, Sison C, Sudilovsky A.
    Psychopharmacol Bull; 1990 Aug 04; 26(3):367-71. PubMed ID: 2274638
    [Abstract] [Full Text] [Related]

  • 40. Nadolol to treat aggression and psychiatric symptomatology in chronic psychiatric inpatients: a double-blind, placebo-controlled study.
    Ratey JJ, Sorgi P, O'Driscoll GA, Sands S, Daehler ML, Fletcher JR, Kadish W, Spruiell G, Polakoff S, Lindem KJ.
    J Clin Psychiatry; 1992 Feb 04; 53(2):41-6. PubMed ID: 1347291
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 3.